55% of UK healthcare professionals reveal payments from industry

29 March 2017

New data from Disclosure UK shows that only 55% of healthcare professionals in the UK are willing to disclose payments from industry.

Disclosure UK is a searchable online database, hosted by the Association of British Pharmaceutical Industry (ABPI), which shows payments and benefits in kind made by pharma companies to doctors and other healthcare professionals.

The figure is lower than the 70% previously quoted. Jon Sussex, chief economist at RAND Europe, who studied the data, explained this was due to “differences in how individual companies had interpreted the data request, which led to inconsistencies in the dataset.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK